home / stock / nbio / nbio quote
Last: | $0.06 |
---|---|
Change Percent: | 5.08% |
Open: | $0.056 |
Close: | $0.06 |
High: | $0.06 |
Low: | $0.056 |
Volume: | 68,000 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.06 | $0.056 | $0.06 | $0.06 | $0.056 | 68,000 | 07-19-2024 |
$0.059 | $0.0695 | $0.059 | $0.0695 | $0.05535 | 200,517 | 07-18-2024 |
$0.06 | $0.065 | $0.06 | $0.0699 | $0.0575 | 487,600 | 07-17-2024 |
$0.0735 | $0.075 | $0.0735 | $0.075 | $0.065 | 35,764 | 07-16-2024 |
$0.0681 | $0.0655 | $0.0681 | $0.071075 | $0.065 | 163,310 | 07-15-2024 |
$0.08435 | $0.075 | $0.08435 | $0.0885 | $0.075 | 95,947 | 07-12-2024 |
$0.076 | $0.076 | $0.076 | $0.076 | $0.076 | 76,000 | 07-11-2024 |
$0.089 | $0.0655 | $0.089 | $0.089 | $0.0655 | 74,000 | 07-10-2024 |
$0.084 | $0.0815 | $0.084 | $0.0845 | $0.0756 | 63,200 | 07-09-2024 |
$0.0815 | $0.07575 | $0.0815 | $0.0815 | $0.07575 | 30,030 | 07-08-2024 |
$0.085 | $0.085 | $0.085 | $0.085 | $0.085 | 875 | 07-05-2024 |
$0.085 | $0.085 | $0.085 | $0.085 | $0.07 | 22,000 | 07-04-2024 |
$0.085 | $0.085 | $0.085 | $0.085 | $0.07 | 22,000 | 07-03-2024 |
$0.07 | $0.0765 | $0.07 | $0.0785 | $0.07 | 103,490 | 07-02-2024 |
$0.0889 | $0.083115 | $0.0889 | $0.0889 | $0.083115 | 57,210 | 07-01-2024 |
$0.0889 | $0.08445 | $0.0889 | $0.0889 | $0.08445 | 14,200 | 06-27-2024 |
$0.0889 | $0.0832 | $0.0889 | $0.0889 | $0.0832 | 32,903 | 06-26-2024 |
$0.0885 | $0.0899 | $0.0885 | $0.0899 | $0.0765 | 52,000 | 06-25-2024 |
$0.0899 | $0.0734 | $0.0899 | $0.0899 | $0.0734 | 63,710 | 06-24-2024 |
$0.0899 | $0.0731 | $0.0899 | $0.0899 | $0.0731 | 23,698 | 06-21-2024 |
News, Short Squeeze, Breakout and More Instantly...
NORTH PALM BEACH, FL / ACCESSWIRE / April 16, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, announces that it is embarking on a fresh manufacturin...
NORTH PALM BEACH, FL / ACCESSWIRE / March 19, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, and HypoSpray Pharma ("HypoSpray ® "), a clinical...
NORTH PALM BEACH, FL and NEW YORK, NY / ACCESSWIRE / February 6, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent"), a clinical-stage biotechnology company pioneering the development of monoclonal antibodies for the treatment of various cancers and viral infections, announc...